Molecure S.A. (WSE:MOC)
Poland
· Delayed Price · Currency is PLN 5.83
-0.06 (-1.02%)
Apr 28, 2026, 5:00 PM CET
Molecure Revenue
In the year 2025, Molecure had annual revenue of 6.52M PLN with 123.34% growth. Molecure had revenue of 2.95M in the quarter ending December 31, 2025, with 29.02% growth.
Revenue
6.52M
Revenue Growth
+123.34%
P/S Ratio
18.42
Revenue / Employee
91.82K
Employees
71
Market Cap
120.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.52M | 3.60M | 123.34% |
| Dec 31, 2024 | 2.92M | -733.54K | -20.08% |
| Dec 31, 2023 | 3.65M | -3.86M | -51.39% |
| Dec 31, 2022 | 7.51M | 6.35M | 543.32% |
| Dec 31, 2021 | 1.17M | -123.74M | -99.07% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mabion | 14.81M |
| NanoGroup | -6.90K |
| Poltreg | 250.00K |
| Urteste | 1.80M |
| Synthaverse | 71.76M |
| BIOTON | 282.52M |
| Pharmena | 1.58M |
| Pure Biologics | -10.52M |